News – Page 704
-
News
Vernalis buys back migraine drug
Vernalis, the biotech company formed from the merger of British Biotech and the original Vernalis, has bought back the rights to its migraine drug from Irish biotech firm Elan.
-
News
Voice of the future
The next major challenge facing UK researchers is to persuade society that scientific method should be at the core of scientific debate, and to diminish the influence of minority protest groups in the public perception of science.
-
News
Cool reception for carbon cuts
Energy company executives are raising renewed concerns over the UK's ambitious plans to cut carbon emissions one year after publication of the government's Energy White Paper.
-
News
Copycat chemistry disarms bugs
Researchers develop protein copies which make bacteria impotent.
-
News
Double beam dream
Researchers at Rutherford Appleton Laboratory in Oxfordshire, UK, are developing what they claim to be the 'most intense laser in the world'.
-
News
EU creates united policy to fight fake drugs
Around the world, counterfeit chemicals present a risk to the public.
-
News
Fighting for the ozone layer
At an intergovernmental meeting in Montreal, Canada in March, participants from 114 countries voted to grant limited 'critical use exemptions' to 11 developed countries facing the 2005 deadline for phasing out methyl bromide.
-
News
Fine tuning cancer-killing molecules
New cancer-beating molecules may be a step closer, thanks to collaboration between chemists and biomedical scientists in Australia.
-
News
French researchers hang up their placards
Scientists make peace with the government, but turn on each other.
-
News
Getting personal with biotechnology
Personalised medicine, which promises to prevent, detect and cure diseases by linking the mechanisms and pathways of illnesses to individuals, will become a reality 'in our lifetime'.
-
News
Joining forces to understand ozone
Three different groups provide new insight into atmospheric reactions.
-
News
Lack of new TB drugs, despite urgent requirement
The global pharmaceutical industry has only 22 compounds in development for treating tuberculosis (TB).
-
News
Microfluidics to help IVF
Microfluidic devices could soon be improving the success of in vitro fertilisation, according to a team of scientists from the universities of Illinois and Wisconsin, US.